Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (21-30 of 450) with videos related to

Pageof 45
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'Vincent Setola, Bryan L Roth
Critical Reviews in Neurobiology|May 3, 2005
Molecular and cellular mechanisms for the polarized sorting of serotonin receptors: relevance for genesis and treatment of psychosisBryan L Roth, Zongqi Xia
Life Sciences|September 17, 2004
Salvinorin A: a novel and highly selective kappa-opioid receptor agonistFeng Yan, Bryan L Roth
Nature Nanotechnology|October 8, 2008
Protein engineering: electrifying cell receptorsAtheir Abbas, Bryan L Roth
Expert Opinion on Pharmacotherapy|December 2, 2008
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disordersAtheir Abbas, Bryan L Roth
Trends in Pharmacological Sciences|March 4, 2023
The structure, function, and pharmacology of MRGPRsCan Cao, Bryan L Roth
Cell|February 5, 2013
Conformational ensembles in GPCR activationEyal Vardy, Bryan L Roth
Nature|May 13, 2018
Activation mechanisms for a universal signalling proteinBrian Krumm, Bryan L Roth
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2010
Allosteric antipsychotics: m4 muscarinic potentiators as novel treatments for schizophreniaMartilias Farrell, Bryan L Roth
Plos Biology|November 21, 2025
Nanobody-drug conjugates for targeting specific GPCR pairsXianglin Huang, Bryan L Roth
Pageof 45

Showing results (21-30 of 450) with videos related to

Sort By:
Pageof 45
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'Vincent Setola, Bryan L Roth
Critical Reviews in Neurobiology|May 3, 2005
Molecular and cellular mechanisms for the polarized sorting of serotonin receptors: relevance for genesis and treatment of psychosisBryan L Roth, Zongqi Xia
Life Sciences|September 17, 2004
Salvinorin A: a novel and highly selective kappa-opioid receptor agonistFeng Yan, Bryan L Roth
Nature Nanotechnology|October 8, 2008
Protein engineering: electrifying cell receptorsAtheir Abbas, Bryan L Roth
Expert Opinion on Pharmacotherapy|December 2, 2008
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disordersAtheir Abbas, Bryan L Roth
Trends in Pharmacological Sciences|March 4, 2023
The structure, function, and pharmacology of MRGPRsCan Cao, Bryan L Roth
Cell|February 5, 2013
Conformational ensembles in GPCR activationEyal Vardy, Bryan L Roth
Nature|May 13, 2018
Activation mechanisms for a universal signalling proteinBrian Krumm, Bryan L Roth
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2010
Allosteric antipsychotics: m4 muscarinic potentiators as novel treatments for schizophreniaMartilias Farrell, Bryan L Roth
Plos Biology|November 21, 2025
Nanobody-drug conjugates for targeting specific GPCR pairsXianglin Huang, Bryan L Roth
Pageof 45